Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 12/20 | 0.45 |
| ▸ | ITGB3 | P05106 | 5/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 5/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 5/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 5/20 | 0.43 |
| ▸ | F10 | P00742 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6600722 | 1.00 | GRM2 (0.45) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6601789 | 1.00 | GRM2 (0.45) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6600484 | 0.93 | GRM2 (0.52) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6603425 | 0.93 | GRM2 (0.46) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6601386 | 0.92 | GRM2 (0.44) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6604843 | 0.92 | F10 (0.48) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6601640 | 0.91 | GRM2 (0.49) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6604063 | 0.91 | GRM2 (0.49) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6601469 | 0.91 | GRM2 (0.49) | GRM2ITGB3PRSS1PRSS2ITGA2B | |
| SCHEMBL6603571 | 0.90 | GRM2 (0.47) | GRM2ITGB3PRSS1PRSS2ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0741133-B1 | Adhesion receptor antagonists | MERCK PATENT GMBH (DE) | 2004-01-28 | — | — | EP | disclosed |
| US-6455529-B1 | OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-09-24 | — | — | US | disclosed |
| EP-0741133-A2 | Adhesion receptor antagonists | MERCK PATENT GmbH (DE) | 1996-11-06 | — | — | EP | disclosed |